Leaping Straight to Neurotoxin Treatments like Botox and Dysport, NextGen Medical Aesthetics Patients Frequently Skip Lower ...

Healthcare data and intelligence provider Guidepoint Qsight today released its latest report on neurotoxin use in the U.S., Qsight Flash Report: Generational Neurotoxin Use Across the United States.

Healthcare data and intelligence provider Guidepoint Qsight has launched its new social media insights platform, Qsight Social Intelligence. Based on proprietary technology developed by Guidepoint ...

NEW YORK, May 24, 2021 /PRNewswire/ — Guidepoint Qsight’s (R) data, which includes proprietary point-of-sale and survey data from hundreds of med spas and physician practices in the U.S., captured a ...

Analyzes rates of cross-purchasing between medical aesthetic procedures, treatments, and products Identifies which categories and treatments have strong affinities, and how these relate over time ...

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Guidepoint Qsight, a leader in leveraging proprietary data to provide unmatched analytics solutions, today announced a new partnership with The Aesthetic ...

WALTHAM, Mass. & SHANGHAI--(BUSINESS WIRE)--(analytica Booth #N2, 2100) PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its new QSight™ ...

New Dashboard Provides Data-Driven Insights on Treatment Pairings and Cross-Purchasing Over Time Analyzes rates of cross-purchasing between medical aesthetic procedures, treatments, and products ...

Qsight estimates $6.4 Billion in total patient spend on neurotoxins in 2024 31% of non-surgical aesthetic spending was on neurotoxins, an 8% increase over 2023 Millennials closing the gap with Gen X ...